Reports on COVID-19 from Chengdu University of Traditional Chinese Medicine Provide New Insights (Development of T Cell Antigen-based Human Coronavirus Vaccines Sars-cov-2 Variants)

MLA

“Reports on COVID-19 from Chengdu University of Traditional Chinese Medicine Provide New Insights (Development of T Cell Antigen-Based Human Coronavirus Vaccines Sars-Cov-2 Variants).” Vaccine Weekly, 11 Sept. 2024, p. 317. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807697929&authtype=sso&custid=ns315887.

APA

Reports on COVID-19 from Chengdu University of Traditional Chinese Medicine Provide New Insights (Development of T Cell Antigen-based Human Coronavirus Vaccines Sars-cov-2 Variants). (2024, September 11). Vaccine Weekly, 317.

Chicago

Vaccine Weekly. 2024. “Reports on COVID-19 from Chengdu University of Traditional Chinese Medicine Provide New Insights (Development of T Cell Antigen-Based Human Coronavirus Vaccines Sars-Cov-2 Variants),” September 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807697929&authtype=sso&custid=ns315887.